Opinion: Progress toward an HIV/AIDS vaccine

Recent successes and ongoing efforts to develop a successful vaccine

Written byHarriet L. Robinson
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Scanning electron micrograph of HIV-1 budding (in green) from cultured lymphocyte WIKIMEDIA COMMONS, CDC, C. GOLDSMITH

A week from today (May 18) marks HIV Vaccine Awareness Day, an occasion designed to salute individuals on the front lines of efforts to develop a preventative vaccine against HIV. The drive to eradicate global AIDS is facing unprecedented challenges, with a report in The New York Times last year describing it as a war we are losing due to financial and technical roadblocks.

Yet tremendous progress is being made towards the development of an effective vaccine. In autumn 2009, a collaborative effort between the Ministry of Health in Thailand, the US Military, and the US National Institute of Allergy and Infectious Disease (NIAID) announced the first encouraging results from an efficacy trial -- 31 percent prevention of infection in a 16,402 person community-based trial ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies